funding-eu EU Horizon Europe HORIZON-HLTH-2027-01 HORIZON-HLTH-2027-01-DISEASE-06 Clinical development, Phase I Clinical trials Dengue

Development of monoclonal antibodies to prevent and treat infections from Flaviviruses

EU — Italia · scadenza 13/04/2027

Development of monoclonal antibodies to prevent and treat infections from Flaviviruses

Scadenza: 13/04/2027

Fonte: eu_funding_tenders

Tipo: EU

Pagina ufficiale: Apri la scheda sulla fonte ufficiale

Scheda (fonte ufficiale)

Topic metadata

EU Programme: Horizon Europe (ID 43108390)
Call identifier: HORIZON-HLTH-2027-01
Call name: Cluster 1 - Health (Single stage - 2027/1)
Type: Topic
Opening date: 10/02/2027
Next deadline: 13/04/2027
Keywords: HORIZON-HLTH-2027-01-DISEASE-06, HORIZON-HLTH-2027-01, Clinical development, Phase I, Clinical trials, Dengue, Disease control, Drug development, clinical phases, Emerging Epidemics

Topic description

Expected Outcome:

This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:

The scientific and clinical communities have a better understanding of and access

Iscriviti o accedi per leggere e ricevere aggiornamenti sui finanziamenti.

Iscriviti ora